Financial Times- Apple's iPhone Growth ERA Comes To An END
Mobihealth News- Mayo Clinic
Cedars Sinai to use Fitbits in small trial of cancer patients - Mayo Clinic
Investor Business Daily
Fitbit fad concern 'overblown'; stock rebounds
BY PATRICK SEITZ
The Fly On The Wall
Netflix analyst commentary at Cantor
Netflix price target raised to $140 from $125 at Cantor. Cantor raised its price target on Netflix after the company reported Q4 results that Cantor views as solid. The firm says that the company's guidance and its international subscriber growth were "impressive"
Adam F negative on SRPT and he's usually right so staying away from SRPT for now.
FDA clarifies the line between wellness and regulated medical devices
By Brian Dolan
January 16, 2015
wait until the wrongful deaths lawsuits, FIT done for. Thanks for the heads up!